CIK: 0001687078 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 17, 2026
Total Value ($000): $873,953 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| AGIO | Agios Pharmaceuticals Inc | 1,303,373 | $35,478 | 4.1% | $35.08 | 0.0% | Common | 00847X104 |
| QURE | Uniqure NV | 1,381,628 | $33,062 | 3.8% | $38.59 | 0.0% | Common | N90064101 |
| ALMS | Alumis Inc | 2,401,992 | $23,443 | 2.7% | $6.98 | 0.0% | Common | 022307102 |
| CRVS | Corvus Pharmaceuticals Inc | 2,743,671 | $21,126 | 2.4% | $7.89 | 0.0% | Common | 221015100 |
| GLUE | Monte Rosa Therapeutics Inc | 1,173,376 | $18,399 | 2.1% | $13.48 | 0.0% | Common | 61225M102 |
| DRUG | Bright Minds Biosciences Inc | 230,147 | $17,961 | 2.1% | $66.83 | 0.0% | Common | 10919W405 |
| PTGX | Protagonist Therapeutics Inc | 199,471 | $17,422 | 2.0% | $81.85 | 0.0% | Common | 74366E102 |
| ARQT | Arcutis Biotherapeutics Inc | 531,200 | $15,426 | 1.8% | $25.60 | 0.0% | Common | 03969K108 |
| VTYX | Ventyx Biosciences Inc | 1,639,061 | $14,801 | 1.7% | $7.47 | 0.0% | Common | 92332V107 |
| BLTE | Belite Bio Inc | 87,760 | $14,038 | 1.6% | $159.96 | — | SPONSORED ADS | 07782B104 |
| RAPT | RAPT Therapeutics Inc | 397,906 | $13,477 | 1.5% | $31.06 | 0.0% | Common | 75382E208 |
| CLYM | Climb Bio Inc | 2,671,480 | $10,686 | 1.2% | $2.40 | 0.0% | Common | 28658R106 |
| ABVX | Abivax SA | 56,316 | $7,594 | 0.9% | $134.85 | — | SPONSORED ADS | 00370M103 |
| MAZE | Maze Therapeutics Inc | 81,145 | $3,362 | 0.4% | $34.37 | 0.0% | Common | 578784100 |
| EVMN | Evommune Inc | 113,022 | $1,935 | 0.2% | $18.78 | 0.0% | Common | 30054Y107 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| LQDA | Liquidia Corp | 1,400,869 (+600.4%) | $48,316 (+962.4%) | 5.5% | $27.50 | +3.5% | Common | 53635D202 |
| RVMD | Revolution Medicines, Inc. | 505,672 (+60.2%) | $40,277 (+173.2%) | 4.6% | $42.93 | +52.7% | Common | 76155X100 |
| URGN | Urogen Pharma Ltd | 941,378 (+597.3%) | $22,047 (+718.6%) | 2.5% | $21.16 | +2.5% | Common | M96088105 |
| PVLA | Palvella Therapeutics Inc | 205,745 (+205.2%) | $21,535 (+409.5%) | 2.5% | $71.96 | +18.5% | Common | 697947109 |
| ENGN | enGene Holdings, Inc. | 1,840,898 (+247.1%) | $16,623 (+359.0%) | 1.9% | $7.02 | +14.2% | Common | 29286M105 |
| ORIC | Oric Pharmaceuticals Inc | 1,798,717 (+4.0%) | $14,714 (-29.1%) | 1.7% | $8.48 | +35.8% | Common | 68622P109 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RNA | Avidity Biosciences Inc | 760,022 | $33,114 | 3.8% | $39.95 | +61.7% | — | 05370A108 |
| ZLAB | Zai Lab Ltd | 745,060 | $25,250 | 2.9% | $26.59 | — | — | 98887Q104 |
| CMPX | Compass Therapeutics, Inc. | 5,075,970 | $17,766 | 2.0% | $1.57 | +193.3% | — | 20454B104 |
| ALKS | Alkermes Plc | 549,262 | $16,478 | 1.9% | $31.51 | -5.0% | — | G01767105 |
| VERA | Vera Therapeutics Inc. | 563,075 | $16,363 | 1.9% | $35.17 | +1.0% | — | 92337R101 |
| JANX | Janux Therapeutics Inc | 614,282 | $15,013 | 1.7% | $39.90 | -41.1% | — | 47103J105 |
| SPRY | ARS Pharmaceuticals Inc | 1,303,399 | $13,099 | 1.5% | $12.03 | -19.2% | — | 82835W108 |
| RARE | Ultragenyx Pharmaceutical Inc | 395,700 | $11,903 | 1.4% | $46.13 | -28.7% | — | 90400D108 |
| WVE | Wave Life Sciences PTE LTD | 1,505,262 | $11,019 | 1.3% | $10.27 | -1.0% | — | Y95308105 |
| SLNO | Soleno Therapeutics Inc | 150,000 | $10,140 | 1.2% | $74.37 | -26.3% | — | 834203309 |
| SLDB | Solid Biosciences Inc | 1,634,569 | $10,085 | 1.2% | $4.28 | +26.6% | — | 83422E204 |
| AKBA | Akebia Therapeutics Inc | 2,889,125 | $7,887 | 0.9% | $2.75 | -23.8% | — | 00972D105 |
| DSGN | Design Therapeutics Inc | 555,187 | $4,181 | 0.5% | $5.79 | +35.3% | — | 25056L103 |
| RNAC | Cartesian Therapeutics Inc | 380,000 | $3,884 | 0.4% | $19.06 | -57.6% | — | 816212302 |
| RAPP | Rapport Therapeutics Inc | 71,807 | $2,133 | 0.2% | $17.84 | +55.1% | — | 75383L102 |
| — | Repare Therapeutics, Inc. | 819,924 | $1,443 | 0.2% | $31.02 | — | — | 760273102 |
| ASMB | Assembly Biosciences Inc | 39,665 | $1,015 | 0.1% | $21.94 | +46.8% | — | 045396207 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| EWTX | Edgewise Therapeutics Inc | 1,655,256 (-3.8%) | $41,075 (+47.2%) | 4.7% | $17.71 | +13.4% | Common | 28036F105 |
| SRPT | Sarepta Therapeutics Inc | 70,000 (-90.0%) | $1,506 (-88.8%) | 0.2% | $29.24 | -27.9% | Common | 803607100 |
| MDGL | Madrigal Pharmaceuticals Inc | 96,780 (-3.6%) | $56,359 (+22.4%) | 6.4% | $328.59 | +55.4% | Common | 558868105 |
| TRVI | Trevi Therapeutics Inc | 3,287,087 (-3.5%) | $41,154 (+32.0%) | 4.7% | $2.95 | +291.6% | Common | 89532M101 |
| DYN | Dyne Therapeutics, Inc. | 1,405,388 (-2.8%) | $27,489 (+50.2%) | 3.1% | $11.01 | +72.0% | Common | 26818M108 |
| DBVT | DBV Technologies S A | 996,825 (-5.5%) | $19,109 (+81.2%) | 2.2% | $9.15 | — | SPONSORED ADS | 23306J309 |
| RCKT | Rocket Pharmaceuticals, Inc. | 1,586,076 (-59.4%) | $5,567 (-56.3%) | 0.6% | $9.83 | -65.2% | Common | 77313F106 |
| RLAY | Relay Therapeutics Inc. | 2,232,451 (-2.2%) | $18,887 (+58.5%) | 2.2% | $10.70 | -33.3% | Common | 75943R102 |
| SNDX | Syndax Pharmaceuticals Inc | 1,337,702 (-2.8%) | $28,105 (+32.8%) | 3.2% | $13.09 | +33.3% | Common | 87164F105 |
| TARS | Tarsus Pharmaceuticals Inc | 328,869 (-3.7%) | $26,928 (+32.7%) | 3.1% | $45.00 | +65.9% | Common | 87650L103 |
| STOK | Stoke Therapeutics Inc | 770,289 (-2.5%) | $24,449 (+31.7%) | 2.8% | $13.06 | +130.2% | Common | 86150R107 |
| PTCT | PTC Therapeutics Inc | 430,013 (-1.9%) | $32,664 (+21.4%) | 3.7% | $40.98 | +77.3% | Common | 69366J200 |
| NTRA | Natera Inc | 93,551 (-5.4%) | $21,432 (+34.6%) | 2.5% | $76.08 | +174.2% | Common | 632307104 |
| HOWL | Werewolf Therapeutics, Inc. | 1,393,557 (-42.1%) | $884 (-81.4%) | 0.1% | $13.70 | -91.1% | Common | 95075A107 |
| XENE | Xenon Pharmaceuticals Inc | 485,620 (-3.5%) | $21,765 (+7.7%) | 2.5% | $37.76 | +11.2% | Common | 98420N105 |
| CNTX | Context Therapeutics Inc | 10,679,391 (-27.4%) | $15,699 (+10.2%) | 1.8% | $1.73 | -32.5% | Common | 21077P108 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CGEM | Cullinan Therapeutics, Inc. | 7,648,268 | $79,160 | 9.1% | $40.60 | -77.8% | Common | 230031106 |